EW vs UGI · P/E 47, rev $1.39B vs P/E 12, rev $7.29B
Edwards Lifesciences Corp (EW) versus UGI Corporation (UGI) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
UGI Corporation (UGI) is a utilities - regulated gas company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported UGI revenue for 2025-09-30 was $7.29B. Net income was $678.0M. Revenue was up 1.1% from 2024-09-30 to 2025-09-30. UGI currently screens at market cap $7.21B and trailing P/E 11.8.
EW currently screens at market cap $49.91B and trailing P/E 46.9. UGI currently screens at market cap $7.21B and trailing P/E 11.8.
Not investment advice. Open the EW and UGI stock pages for the full models.
Not investment advice.